Yucca: A medicinally significant genus with manifold therapeutic attributes

doi:10.1007/s13659-012-0090-4

Abstract

Abstract: The genus Yucca comprising of several species is dominant across the chaparrals, canyons and deserts of American South West and Mexico. This genus has long been a source of sustenance and drugs for the Native Americans. In the wake of revived interest in drug discovery from plant sources, this genus has been investigated and startling nutritive and therapeutic capacities have come forth. Apart from the functional food potential, antioxidant, antiinflammation, antiarthritic, anticancer, antidiabetic, antimicrobial, and hypocholesterolaemic properties have also been revealed. Steroidal saponins, resveratrol and yuccaols have been identified to be the active principles with myriad biological actions. To stimulate further research on this genus of multiple food and pharmaceutical uses, this updated review has been prepared with references extracted from MEDLINE database.

Key words: Yucca, saponin, antioxidant, cytotoxicity, antimicrobial

摘要： The genus Yucca comprising of several species is dominant across the chaparrals, canyons and deserts of American South West and Mexico. This genus has long been a source of sustenance and drugs for the Native Americans. In the wake of revived interest in drug discovery from plant sources, this genus has been investigated and startling nutritive and therapeutic capacities have come forth. Apart from the functional food potential, antioxidant, antiinflammation, antiarthritic, anticancer, antidiabetic, antimicrobial, and hypocholesterolaemic properties have also been revealed. Steroidal saponins, resveratrol and yuccaols have been identified to be the active principles with myriad biological actions. To stimulate further research on this genus of multiple food and pharmaceutical uses, this updated review has been prepared with references extracted from MEDLINE database.

关键词: Yucca, saponin, antioxidant, cytotoxicity, antimicrobial

Seema PATEL. Yucca: A medicinally significant genus with manifold therapeutic attributes[J]. Natural Products and Bioprospecting, 2012, 2(6): 231-234.

Seema PATEL. Yucca: A medicinally significant genus with manifold therapeutic attributes[J]. 应用天然产物, 2012, 2(6): 231-234.

References

[1] Marzocco, S.; Piacente, S.; Pizza, C.; Oleszek, W.; Stochmal, A.; Pinto, A.; Sorrentino, R.; Autore, G. Life Sci. 2004, 75, 1491-1501.
[2] Kishor N; Sati OP; Sakakibara J; Kaiya T. Phytochemistry 1992, 31, 706-707.
[3] Uematsu, Y.; Hirata, K.; Saito, K.; Kudo, I. J AOAC Int. 2000, 83, 1551-1454.
[4] Sucharzewska, D.; Stochmal, A.; Oleszek, W. LWT-Food Sci. Technol. 2003, 36, 347-351.
[5] Piacente, S.; Pizza, C.; Oleszek, W. Phytochem. Rev. 2005, 4, 177-190.
[6] Andreuccetti, C.; Carvalho, R. A.; Galicia-García, T.; MartínezBustos, F.; Grosso, C. R. F. J. Food Eng. 2011, 103, 129-136.
[7] Torres, P.; Avila, J. G.; de Vivar, A. R.; Garci?a, A. M.; Mari?n, J. C.; Aranda, E.; Céspedes, C. L. Phytochemistry 2003, 64, 463-473.
[8] Olas, B.; Wachowicz, B.; Stochmal, A.; Oleszek, W. Nutrition 2003, 19, 633-640.
[9] Olas, B.; Wachowicz, B.; Majsterek, I.; Blasiak, J.; Stochmal, A.; Oleszek, W. Nutrition 2006, 22, 1202-1209.
[10] Balestrieri, C.; Felice, F.; Piacente, S.; Pizza, C.; Montoro, P.; Oleszek, W.; Visciano, V.; Balestrieri, M. L. Biochem. Pharmacol. 2006, 71, 1479-1487.
[11] Bassarello, C.; Bifulco, G.; Montoro, P.; Skhirtladze, A.; Benidze, M.; Kemertelidze, E.; Pizza, C.; Piacente, S. J. Agric. Food Chem. 2007, 55, 6636-6642.
[12] Bassarello, C.; Bifulco, G.; Montoro, P.; Skhirtladze, A.; Kemertelidze, E.; Pizza, C.; Piacente, S. Tetrahedron. 2007, 63, 148-154.
[13] Montoro, P.; Skhirtladze, A.; Bassarello, C.; Perrone, A.; Kemertelidze, E.; Pizza, C.; Piacente, S. J Pharma. Biomed. Anal. 2008, 47, 854-859.
[14] Cigerci, I. H.; Fidan, A. F.; Konuk, M.; Yuksel, H.; Kucukkurt, I.; Eryavuz, A.; Sozbilir, N. B. J. Nat. Med. 2009, 63, 311-317.
[15] Ince, S.; Kucukkurt, I.; Turkmen, R.; Demirel, H. H.; Sever, E. Toxicol. Ind. Health. 2012, PMID 22609855.
[16] Mouli, K. C.; Vijaya, T.; Rao, S. D. J. Global Pharma. Technol. 2009, 1, 4-18.
[17] Backer, R. C.; Bianchi, E.; Cole, J. R. J. Pharma. Sci. 2006, 61, 1665-1666.
[18] Fidan, A. F.; Dundar, Y. J. Diabetes Complications 2008, 22, 348-356.
[19] Kim, S. W.; Park, S. K.; Kang, S. I.; Kang, H. C.; Oh, H. J.; Bae, C. Y.; Bae, D. H. Arch. Pharm. Res. 2003, 26, 1042-1046.
[20] Miyakoshi, M.; Tamura, Y.; Masuda, H.; Mizutani, K.; Tanaka, O.; Ikeda, T.; Ohtani, K.; Ksai, R.; Yamamsaki, K. J. Nat. Prod. 2000, 63, 332-338.
[21] McAllister, T. A.; Annett, C. B.; Cockwill, C. L.; Olson, M. E.; Wang, Y.; Cheeke P. R. Vet. Parasito. 2001, 97, 85-99.
[22] Cheeke, P. R.; Piacente, S.; Oleszek, W. J. Inflamm. 2006, 3, 6.
[23] Jin, Y. L.; Kuk, J. H.; Oh, K. O.; Kim, Y. J.; Piao, X. L.; Park, R. D. Arch. Pharma. Res. 2007, 30, 543-546.
[24] Zhang, Y.; Zhang, Y. J.; Jacob, M. R.; Li, X. C.; Yang, C. R. Phytochemistry 2008, 69, 264-270.
[25] Kemertelidze, E. P.; Benidze, M. M.; Skhirtladze, A. V. Pharma. Chem. J. 2009, 43, 45-47.
[26] Wang, L. J.; Weller, C. L. Trends Food Sci. Technol. 2006, 17, 300-312.
[27] Montoro, P.; Skhirtladze, A.; Perrone, A; Benidze, M.; Kemertelidze, E.; Piacente, S. J. Pharma. Biomed. Anal. 2010, 52, 791-795.
[28] Sautour, M.; Miyamoto, T.; Lacaille-Dubois, M. A. Phytochemistry 2007, 68, 2554-2562.
[29] Yokosuka, A.; Mimaki, Y. Phytochemistry 2009, 70, 87-815.
[30] Li, H.; Huang, W.; Wen, Y.; Gong, G.; Zhao, Q.; Yu, G. Fitoterapia 2010, 81, 1147-1156.
[31] Wu, X.; Wang, L.; Wang, H.; Dai, Y.; Ye, W. C.; Li, Y. L. Phytochemistry 2012, 81, 133-143.